This systemic chronic inflammation not only directly damages the vascular endothelium but also further inhibits tyrosine phosphorylation of insulin receptor substrate (IRS) by activating the classic IKKβ-NF-κB molecular pathway, exacerbating insulin resistance [50, 51]. The gene discussed is NFKB1; the disease is Insulin resistance.